American College of Cardiology https://www.bioworld.com/rss en-us VB-19055 exerts antihypertensive effects http://www.bioworld.com/articles/730190 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730190-vb-19055-exerts-antihypertensive-effects Blood pressure monitor Braveheart finds phase II positive for cardiac myosin inhibitor http://www.bioworld.com/articles/729968 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729968-braveheart-finds-phase-ii-positive-for-cardiac-myosin-inhibitor 3D illustration of heart cross section TY-1 ameliorates hypertrophy in mice with HCM http://www.bioworld.com/articles/730039 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730039-ty-1-ameliorates-hypertrophy-in-mice-with-hcm Illustration of heart analysis for DNA and drug impacts Boston Sci boasts Champion-AF data but strokes signal a concern http://www.bioworld.com/articles/729948 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729948-boston-sci-boasts-champion-af-data-but-strokes-signal-a-concern Boston Scientific - Watchman FLX Watchman FLX. Credit: Boston Scientific Corp. Plaque levels on AI-enhanced CCT impart greater relative risk for women http://www.bioworld.com/articles/718874 Mon, 07 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/718874-plaque-levels-on-ai-enhanced-cct-impart-greater-relative-risk-for-women Heart scientific overlay CMS rolls out draft coverage memo for TEER for the tricuspid valve http://www.bioworld.com/articles/718872 Mon, 07 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/718872-cms-rolls-out-draft-coverage-memo-for-teer-for-the-tricuspid-valve Edwards Lifesciences - Evoque tricuspid valve replacement device GE Healthcare taps into Japan radiopharma market with Nihon buy http://www.bioworld.com/articles/718642 Wed, 02 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/718642-ge-healthcare-taps-into-japan-radiopharma-market-with-nihon-buy GE Healthcare Hospitalizations decline shows clearer benefit in Triclip study http://www.bioworld.com/articles/718636 Tue, 01 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/718636-hospitalizations-decline-shows-clearer-benefit-in-triclip-study 4-9-Abbott-Triclip.png Triclip device. Credit: Abbott Laboratories Edwards’ Early TAVR refutes surveillance recs for aortic stenosis http://www.bioworld.com/articles/718635 Tue, 01 Apr 2025 12:00:00 -0400 https://www.bioworld.com/articles/718635-edwards-early-tavr-refutes-surveillance-recs-for-aortic-stenosis Edwards-SAPIEN3-12-6.png Sapien 3 valve and delivery system. Credit: Edwards Lifesciences Corp. At 5 years, TAVR as good as SAVR in low-risk patients http://www.bioworld.com/articles/718626 Mon, 31 Mar 2025 12:00:00 -0400 https://www.bioworld.com/articles/718626-at-5-years-tavr-as-good-as-savr-in-low-risk-patients Evolut device image Evolut Pro+ TAVR device. Credit: Medtronic plc AI-enhanced ECG readings beat clinicians and labs in identifying MI http://www.bioworld.com/articles/718625 Mon, 31 Mar 2025 12:00:00 -0400 https://www.bioworld.com/articles/718625-ai-enhanced-ecg-readings-beat-clinicians-and-labs-in-identifying-mi Blood pressure gauge, ECG and medication Smartheart study reveals drop in hospital readmissions, ED visits holland.johnson@clarivate.com http://www.bioworld.com/articles/707169 Fri, 12 Apr 2024 12:00:00 -0400 https://www.bioworld.com/articles/707169-smartheart-study-reveals-drop-in-hospital-readmissions-ed-visits Smartheart image Visual Abstract from TELE-ACS trial presentation at ACC24 Get SMART: Medtronic’s Evolut TAVR outperforms Edwards Sapien in trial holland.johnson@clarivate.com http://www.bioworld.com/articles/707139 Tue, 09 Apr 2024 12:00:00 -0400 https://www.bioworld.com/articles/707139-get-smart-medtronics-evolut-tavr-outperforms-edwards-sapien-in-trial Evolut device image Evolut Pro+ TAVR device. Credit: Medtronic plc Research possible harbinger for broader intervention guidelines treating AS http://www.bioworld.com/articles/695216 Thu, 16 Mar 2023 13:00:00 -0400 https://www.bioworld.com/articles/695216-research-possible-harbinger-for-broader-intervention-guidelines-treating-as Flowtriever System scores whopping 90% survival improvement during high-risk PE study http://www.bioworld.com/articles/695012 Fri, 10 Mar 2023 13:00:00 -0500 https://www.bioworld.com/articles/695012-flowtriever-system-scores-whopping-90-survival-improvement-during-high-risk-pe-study Flowtriever system The Flowtriever System recently demonstrated a >90% lower all-cause mortality rate in patients suffering from high-risk pulmonary embolism (PE). Analysis of claims data says 10-year data for reintervention a success story for TAVR devices http://www.bioworld.com/articles/694877 Tue, 07 Mar 2023 13:00:00 -0500 https://www.bioworld.com/articles/694877-analysis-of-claims-data-says-10-year-data-for-reintervention-a-success-story-for-tavr-devices Illustration of TAVR device Medtronic pulls ahead of the field for PFA ablation via PULSED AF study http://www.bioworld.com/articles/694873 Tue, 07 Mar 2023 13:00:00 -0500 https://www.bioworld.com/articles/694873-medtronic-pulls-ahead-of-the-field-for-pfa-ablation-via-pulsed-af-study Medtronic Pulse Select Medtronic Pulse Select Abbott Triclip shows well for symptom relief, but hurdles remain for mortality, hospitalization http://www.bioworld.com/articles/694835 Mon, 06 Mar 2023 13:00:00 -0500 https://www.bioworld.com/articles/694835-abbott-triclip-shows-well-for-symptom-relief-but-hurdles-remain-for-mortality-hospitalization COAPT data support Mitraclip in secondary regurgitation, but conflict with MITRA-FR study http://www.bioworld.com/articles/694832 Mon, 06 Mar 2023 13:00:00 -0500 https://www.bioworld.com/articles/694832-coapt-data-support-mitraclip-in-secondary-regurgitation-but-conflict-with-mitra-fr-study Product image Mitraclip device. Credit: Abbott Laboratories Renal denervation not yet prepared to move medications to the side http://www.bioworld.com/articles/517637 Tue, 05 Apr 2022 13:00:00 -0400 https://www.bioworld.com/articles/517637-renal-denervation-not-yet-prepared-to-move-medications-to-the-side 3-30-Medtronic-Symplicity-Spyral.png Symplicity Spyral renal denervation system. Credit: Medtronic plc One-year data for Edwards’ Pascal support improvements in mortality numbers http://www.bioworld.com/articles/517636 Tue, 05 Apr 2022 13:00:00 -0400 https://www.bioworld.com/articles/517636-one-year-data-for-edwards-pascal-support-improvements-in-mortality-numbers 3D heart illustration showing tricuspid and bicuspid valves Study hints electronic health records may change trajectory of heart failure outcomes http://www.bioworld.com/articles/517580 Mon, 04 Apr 2022 13:00:00 -0400 https://www.bioworld.com/articles/517580-study-hints-electronic-health-records-may-change-trajectory-of-heart-failure-outcomes Tablet, health professional, EHR/medical icons Mavacamten, ablation poised to clash over treatment of hypertrophic cardiomyopathy http://www.bioworld.com/articles/517579 Mon, 04 Apr 2022 13:00:00 -0400 https://www.bioworld.com/articles/517579-mavacamten-ablation-poised-to-clash-over-treatment-of-hypertrophic-cardiomyopathy 3D heart in chest Study of surgical LAA closure could boost percutaneous device sales http://www.bioworld.com/articles/507233 Tue, 18 May 2021 13:00:00 -0400 https://www.bioworld.com/articles/507233-study-of-surgical-laa-closure-could-boost-percutaneous-device-sales 3D heart in chest Conference data for May 17, 2021: ACC http://www.bioworld.com/articles/507146 Mon, 17 May 2021 11:00:00 -0400 https://www.bioworld.com/articles/507146-conference-data-for-may-17-2021-acc Excellent outcomes for Medtronic Evolut TAVR in low-risk bicuspid AVS patients http://www.bioworld.com/articles/434102 Tue, 31 Mar 2020 13:00:00 -0400 https://www.bioworld.com/articles/434102-excellent-outcomes-for-medtronic-evolut-tavr-in-low-risk-bicuspid-avs-patients 3-31-Medtronic-Evolut-PRO.png Evolut Pro TAVR system. Credit: Medtronic plc Conference data for March 31, 2020: ACC.20/WCC Virtual http://www.bioworld.com/articles/434069 Tue, 31 Mar 2020 11:00:00 -0400 https://www.bioworld.com/articles/434069-conference-data-for-march-31-2020 Renal denervation significantly reduces untreated hypertension http://www.bioworld.com/articles/434060 Mon, 30 Mar 2020 13:00:00 -0400 https://www.bioworld.com/articles/434060-renal-denervation-significantly-reduces-untreated-hypertension 3-30-Medtronic-Symplicity-Spyral.png Symplicity Spyral renal denervation system. Credit: Medtronic plc Conference data for March 30, 2020: ACC.20/WCC Virtual http://www.bioworld.com/articles/434044 Mon, 30 Mar 2020 11:00:00 -0400 https://www.bioworld.com/articles/434044-conference-data-for-march-30-2020